| 000 | 00942 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250518074542.0 | ||
| 264 | 0 | _c20200415 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a1365-2036 | ||
| 024 | 7 |
_a10.1111/apt.15520 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaharie, David | |
| 245 | 0 | 0 |
_aLetter: should we intensify infliximab in acute severe ulcerative colitis? _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _c01 2020 |
||
| 300 |
_a186-187 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aColitis |
| 650 | 0 | 4 | _aColitis, Ulcerative |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aPropensity Score |
| 650 | 0 | 4 | _aRetrospective Studies |
| 700 | 1 | _aRivière, Pauline | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 51 _gno. 1 _gp. 186-187 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/apt.15520 _zAvailable from publisher's website |
| 999 |
_c30433790 _d30433790 |
||